Sheba Medical Center, the largest hospital in the Middle East region, and Lonza, a global cell and gene therapy manufacturer, have treated multiple patients with CD19 CAR-T cell immunotherapy targeting B-cell malignancies, with three patients showing complete responses, and another patient is still being evaluated.   All patients were dosed with therapies manufactured in Lonza’s Cocoon Platform, an automated, customizable, patient-scale cell therapy platform that streamlines manufacturing to i...